Despite the well-characterized roles of BARD1 in genome maintenance, BARD1 isoforms that lack the BRCA1-interacting domain or other critical regions may lose tumor-suppressive capabilities and instead contribute to tumorigenesis. This evidence concerns the gene BRCA1 and neoplasm.